General discussion, page-5144

Good work @thevinnys - excellent summary.

TBH, there's not much to say on $IHL, which is why we've been quiet.

The train has left the station and is starting to accelerate quickly...

We trust the BOD to get the job done, which isn't going to happen overnight.

We all know that IHL is dealing in drug development with PROVEN scientific research (ie. OSA, TBI, psychedelics etc), which we laid out extensively on the blog. The scientific research for each drug is substantial, mind you. It's just a matter of patience and waiting for delivery now.

Expecting a massive amount of news flow in the months ahead, for example:
- FDA announcement for IHL-675A, which should pave the road forward for human trials - the market should take us a little more seriously...
- OSA trial update and results (potentially leading up to the US market listing) - this could be MASSIVE! We already know dronabinol works for OSA.
- US market listing on NASDAQ which might be the highlight of the year, share price wise...
- Psychedelics trial, likely following NASDAQ listing + another potential psychedelics trial (flagged by thevinneys and others). Psychedelics could replace antidepressants this decade. (laugh all you want...but see how quickly the world has warmed to medical cannabis).
- much, much more...ie. TBI update etc.

Folks, we image that the BOD are lining this duck up right now and come the second half of the year, the share price will be well over 50c...assuming everything goes to plan as above.
Nothing to do, but to just sit back and enjoy the show.
To your first million,
-Trading For Millions